MSK Commack — Commack, New York

MSK Commack is a clinical research site located in Commack, New York, United States 11725.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

MSK Commack has participated in 20 clinical trials with 14 currently active.

Therapeutic areas: Muscle-invasive Urothelial Carcinoma, Multiple Myeloma, Colorectal Neoplasms.

Sponsors: Hoffmann-La Roche, Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Commack

Browse all research sites in New York · View every site in Commack

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Commack?

MSK Commack has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Commack conducted?

MSK Commack has 20 clinical trials on record, with 14 currently active. Their work covers Muscle-invasive Urothelial Carcinoma, Multiple Myeloma, Colorectal Neoplasms.

Is MSK Commack accredited by Crixeo Clinical Trials?

MSK Commack has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSK Commack?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.